Preferences help
enabled [disable] Abstract
Number of results
2015 | 86 | 5 | 211-217
Article title

Serum Leptin and Ghrelin Levels in Patients in the Early Stages of Acute Biliary Pancreatitis and Different Degrees of Severity

Title variants
Languages of publication
Acute pancreatitis (AP) is a potentially fatal disease. In animal experiments leptin and ghrelin were shown to modulate the course of AP. The aim of the study was to estimate the relationship between the severity of acute biliary pancreatitis (ABP) and serum levels of leptin and ghrelin in nonobese patients in the first seven days of the hospitalization. Material and methods. The study included nine patients with mild ABP (MABP), eleven patients with severe ABP (SABP) and twenty healthy controls, appropriately matched age, sex and weight. Serum concentrations of leptin and ghrelin were measured in patients on the first, third, fifth, and seventh days of hospitalization using leptin and ghrelin RadioImmunoAssay (RIA) kits. Results. At admission and throughout the study the mean serum leptin concentration in SABP patients was higher than in the controls but without statistical significance. Serum ghrelin concentrations on admission were significantly lower in patients with ABP than in the controls. We observed steadily increasing serum ghrelin levels in both groups of the patients during the course of ABP. Conclusions. The results of our study do not support the role of leptin as a marker of the severity of ABP. On the other hand, rising serum ghrelin levels during the course of ABP may be a marker of recovery and an indicator of the healing process
Physical description
1 - 5 - 2014
1 - 7 - 2014
15 - 4 - 2014
  • 2nd Department of General Surgery, Jagiellonian University Medical College in Cracow, Kierownik: prof. dr hab. A. Wysocki
  • Department of Medical Physiology Faculty of Health Sciences, Jagiellonian University Medical College in Cracow, Kierownik: prof. dr hab. J. Jaworek
  • School of Medicine in English, Jagiellonian University Medical College in Cracow, Kierownik: prof. dr hab. J. Walocha
  • Department of Medical Physiology Faculty of Health Sciences, Jagiellonian University Medical College in Cracow, Kierownik: prof. dr hab. J. Jaworek
  • 1. Mofleh IA: Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol 2008; 14: 675-84.[Crossref][PubMed][WoS]
  • 2. Sekimoto M, Takada T, Kawarada Y et al.: JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 2006; 13: 10-24.[Crossref]
  • 3. Dembiński A, Warzecha Z, Ceranowicz P et al.: Ghrelin attenuates the development of acute pancreatitis In rats. J Physiol Pharmacol 2003; 54: 561-73.[PubMed]
  • 4. Ceranowicz D, Warzecha Z, Dembiński A et al.: Role of hormon al axis, growth hormone -IGF-1, in the therapeutic effect of ghrelin in the course of cerulean-induced acute pancreatitis. J Physiol Pharmacol 2010; 61: 599-606.
  • 5. Jaworek J: Ghrelin and melatonin in the regulation of pancreatic exocrine secretion and maintaining of integrity. J Physiol Pharmacol 2006; 57 (Suppl 5): 83-96.[PubMed]
  • 6. Konturek PC, Jaworek J, Maniatoglou A et al.: Leptin modulates the inflammatory response in acute pancreatitis. Digestion 2002; 65: 149-160.[PubMed][Crossref]
  • 7. Gultekin FA, Kerem M, Taticioglu E et al.: Leptin treatment ameliorates acute lung injury in rats with cerulein- induced acute pancreatitis. World J Gastroenterol 2007; 132: 2932-38.
  • 8. Zhou Xia, Chengrui Xue: Ghrelin inhibits the development of acute pancreatitis and nuclear factor (kappa)B activation in pancreas and liver. Pancreas 2009; 38: 752-57.[WoS][Crossref]
  • 9. Warzecha Z, Ceranowicz P, Dembinski A et al.: Therapeutic effect of ghrelin in the course of cerulein- induced acute pancreatitis in rats. Physiol Pharmacol 2010; 61: 419-27.
  • 10. Brennan AM, Mantzoros CS: Drug Insight: the role of leptin in human physiology and pathophysiology - emerging clinical applications. Nat Clin Pract Endocrinol Metab 2006; 2: 318-27.[Crossref][PubMed]
  • 11. Navina S, Acharya C, Delany JP et al.: Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med 2011; 3: 107-10.[WoS]
  • 12. Koutsari CJ: Thematic review series: patientoriented research. Free fatty acid metabolism in human obesity. J Lipid Res 2006; 47: 1643-50.[Crossref]
  • 13. Ray K: Obesity: Unsaturated fatty acids aggravate acute pancreatitis Nature Rev Gastroenterol Hepatol 2012; 9: 5.
  • 14. Considine RV, Sinha MK, Heiman ML et al.: Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 1996: 334: 292-95.
  • 15. Kerem M, Bedirli A, Pasaoglu H et al.: Role of ghrelin and leptin in predicting the severity of acute pancreatitis. Dig Dis Sci 2007; 52: 950-55.[Crossref][WoS][PubMed]
  • 16. K ojima M, Hosoda H, Date Y et al.: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
  • 17. Sangiao-Alvarellos S, Vázquez MJ, Varela L et al.: Role of ghrelin and leptin in predicting the severity of acute pancreatitis. Dig Dis Sci 2007; 52: 950-55.[WoS]
  • 18. Rindi G, Torsello A, Locatelli V, Solcia E: Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system. Exp Biol Med (Marywood) 2004; 229: 1007-16.
  • 19. Granata R: Ghrelin and the endocrine pancreas. Endocrine 2008; 16 S7.2 (Abstracts)
  • 20. Bradley III EL: A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128: 586-90.
  • 21. Ranson JHC, Rifkind KM, Roses DF et al.: Prognostic sings and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139: 69-81.
  • 22. Knaus W, Draper E, Wagner DP et al.: APPACHE II: a severity of disease classification system. Crit Care Med 1985; 77: 633-38.
  • 23. Becker V: Pathological anatomy and pathogenesis of acute pancreatitis. World J Surg 1981; 5: 303-13.[PubMed][Crossref]
  • 24. Balthazar EJ: CT diagnosis and standing of acute pancreatitis. Radiol Clin North Am 1989; 27: 19-37.
  • 25. Marshall JC, Sibbald WJ, Cook DA et al.: The multiple organ dysfunction score: A reliable indicator of a complex clinical outcome. Crit Care Med 1992; 20: S90.
  • 26. Kwon, O-W, Choi H-S, Han, S-H et al.: Serum leptin and ghrelin level in acute pancreatitis: J Gastroenterol Hepatol 2005; 20 (Suppl 2): A267 (Abstract).
  • 27. T ukiainen E, Kylanpaa M-L, Ebeling P et al.: Leptin and adiponectin levels in acute pancreatitis. Pancreas 2006; 32: 211-14.[PubMed]
  • 28. Duarte-Rojo A, Lezema A, Ramirenz MT et al.: Is leptin related to systemic response in acute pancreatitis? World J Gastroenterol 2006; 12: 4392-26.
  • 29. Zhou X, Xue C: Ghrelin attenuates acute pancreatitis- induced lung Injury and inhibits substance P expression. Am J Med Sci 2010; 339: 49-54.
  • 30. L ee S H, Kim YD, Kong YH et al.: The relevance of serum ghrelin concentration to severity of acute pancreatitis. Gut Liver 2010; 4: 234-40.[WoS]
  • 31. Liu B, Liu X, Tang C: Change of plasma ghrelin level in acute pancreatitis. Pancreatology 2006; 6: 531-35.[PubMed][Crossref]
  • 32. Daniel P, Leśniowski B, Jasińska A et al.: Usefulness of assessing circulating levels of resistin, ghrelin, and IL-18 in alcoholic acute pancreatitis. Dig Dis Sci 2010; 55: 2982-87.[Crossref][WoS][PubMed]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.